Marina Nikanorova

Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders

Markus Wolff, Katrine M. Johannesen, Ulrike B. S. Hedrich et al. · Brain · 2017 · 558 citations · Full text

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial

Lieven Lagae, Joseph Sullivan, Kelly G. Knupp et al. · The Lancet · 2019 · 348 citations

Dravet Syndrome, Fenfluramine Hydrochloride, Medicine +5

<i>GABRA1</i> and <i>STXBP1</i> : Novel genetic causes of Dravet syndrome

Gemma L. Carvill, Sarah Weckhuysen, Jacinta M. McMahon et al. · Neurology · 2014 · 254 citations · Full text

Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures

Gemma L. Carvill, Jacinta M. McMahon, Amy Schneider et al. · The American Journal of Human Genetics · 2015 · 221 citations · Full text

Neurobiology Of Disease, Molecular Neuroscience, Neurophysiology +9

Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial

Ettore Beghi, G. Gatti, Clara Tonini et al. · Epilepsy Research · 2003 · 159 citations

Single Drug, Psychiatry, Partial Epilepsy +5